Site US10013 — New York, New York

Site US10013 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10013 has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Leukemia, Acute Myeloid (AML).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10013?

Site US10013 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10013 conducted?

Site US10013 has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia, Leukemia, Acute Myeloid (AML).

Is Site US10013 accredited by Crixeo Health?

Site US10013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.